查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2050416

全球牙科骨植體市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Dental Bone Graft Substitute Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Allografts, Xenografts, and Synthetic Grafts
出版日期: | 出版商: iData Research Inc. | 英文 73 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球牙科骨植體市場報告（至2032年）

2025年全球牙科骨植體市場規模為11.9億美元。預計到2032年，該市場將以7.3%的年複合成長率成長，達到約19.5億美元。

這份綜合報告涵蓋了全球牙科骨植體市場，包括同種異體移植、異質骨移植和合成牙科骨移植骨植體（DBGS）產品。

該分析包括銷售量、平均售價 (ASP)、市場規模、成長趨勢、市場促進因素和限制因素、截至 2032 年的市場預測以及截至 2022 年的歷史數據。它還涵蓋了近期併購、公司簡介、產品系列和主要參與者。

全球人工植牙手術的擴張、臨床醫生在植牙手術方面經驗的累積以及生物來源種植材料的日益普及推動了市場成長。然而，成本障礙、牙科治療技術的進步以及生物來源材料接受度的地區差異仍然影響著市場趨勢。

市場概覽

全球牙科骨植體市場涵蓋用於牙科治療的材料，包括修復骨缺損、準備植入位點和促進骨再生。牙科骨植體（DBGS）產品最常用於與植入相關的手術，例如齒槽窩保存術、上顎竇提升術和齒槽骨增高術。

在市場區隔中，骨移植材料分為同種異體骨移植、異種骨移植和合成骨移植。同種異體骨移植來自人類捐贈組織，異種骨移植來自牛、豬等動物材料，而合成骨移植則由非生物材料製成。

到2025年，異種移植材料將佔據市場總佔有率的最大部分。由於其供應充足、品質穩定且臨床療效顯著，異種移植產品在許多地區已廣泛應用。同種移植材料將佔據第二大市場佔有率，尤其在北美地區應用最為廣泛。

合成DBGS產品是目前市場佔有率最小的材料類別，但預計在預測期內其佔有率將有所成長。這一成長得益於人們對感染疾病傳播的擔憂較低、生產擴充性，以及在人源或動物源性移植材料面臨監管、文化或供應限制的地區，合成DBGS產品的應用前景廣闊。

市場促進因素

消費者意識的提高是牙科骨移植市場的主要驅動力。隨著人工植牙的普及，對骨移植材料的需求不斷成長，因為許多植入患者在植入前需要進行植入前準備。這意味著牙科骨移植市場的成長與更廣泛的人工植牙市場直接相關。

目前，許多人工植牙公司在植入系統之外還提供再生材料。這促使行銷、臨床醫生教育以及與骨移植材料相關的專項銷售工作不斷增加。隨著各公司將骨移植作為完整植入治療流程的一部分進行推廣，越來越多的臨床醫生和患者認知到骨再生材料在植入治療成功中所發揮的重要作用。

臨床醫師經驗的累積也推動了市場成長。進行骨移植手術的牙科專業人員對現有材料和技術越來越熟悉。這促使他們更多地使用更先進的產品，例如皮質骨-鬆質骨混合異體移植片和含有鈣化骨碎片的脫鈣骨基質（DBM）糊劑。隨著臨床醫師信心的增強，價格較高的產品在先進的再生療法中也變得越來越普遍。

市場限制

口腔健康狀況的改善將成為牙骨移植市場長期發展的限制因素。在許多地區，口腔衛生意識的提高和牙科檢查頻率的增加導致無牙症病例減少。即使人口老化，老年人的牙齒狀況也比前幾代人更好，這可能意味著在某些市場，需要大規模骨移植的患者群體正在萎縮。

大規模骨移植手術費用昂貴，阻礙了普及。例如，齒槽脊增加術可能需要5至10毫升的移植材料。在某些情況下，移植部分的費用甚至可能超過人工植牙本身的費用，這會對患者造成經濟負擔。

生物來源移植材料的地區接受度也可能限制其應用。儘管加工、滅菌和可追溯性方面的進步提高了人們對同種異體和異種移植材料的信心，但它們的應用仍然因法規、文化偏好、供體組織可用性和臨床醫生接受度而異。這些因素可能會限制其在某些國家的發展，同時可能推動合成移植材料的使用。

市場覆蓋範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、市場預測、市場成長率、銷售量、平均售價。
  • 定性範圍：市場促進因素和限制因素、市場規模和成長趨勢、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 資料類型包括：銷售量、平均售價、市場規模和成長趨勢、市場促進因素和阻礙因素、到 2032 年的市場預測、歷史資料、近期併購、公司簡介和產品系列。
  • 方法注記：市場收入採用銷售量和平均售價進行建模，同種異體移植、異種移植和合成DBGS產品的需求透過按移植材料和應用進行細分進行評估。

本報告旨在幫助讀者評估人工植牙成長、材料選擇、生物植入物的接受度、區域滲透率和患者經濟負擔等因素如何影響全球牙科骨植體市場。

目標市場及區隔

牙科骨植體市場

  • 類型：同種異體接枝材料、異種異體接枝材料及複合材料。
  • 用途：齒槽窩保存、上顎竇增高術、齒槽脊增加及牙周治療。

按應用進行細分僅在單元層級進行分析。

同種異體移植材料包括用於牙齒再生療法的人類來源移植材料。這些產品在北美尤其重要，因為北美的組織庫基礎設施完善，臨床醫師對其接受度也較高。

異質骨移植包括動物性移植材料，最常見於牛或豬。該領域在全球牙科骨移植（DBGS）市場價值中佔據最大佔有率。

合成DBGS產品是人工製造的移植替代品，並非源自人類或動物。在生物移植面臨監管、文化或供應限制的市場中，這些產品至關重要。

透過市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價等相關定量指標對每個細分市場進行分析。

競爭分析

2025年，蓋斯特利希公司繼續保持其在全球牙科骨移植市場領先地位。其領先地位主要得益於其在異種移植領域的強大實力，該領域在北美以外的牙科骨移植市場中佔據了相當大的佔有率。該公司的Bio-Oss®牛移植產品組合被廣泛認可為臨床標準，擁有長期的臨床證據和全球應用的成功記錄。

蓋斯特利希公司持續改進並拓展其Bio-Oss®產品線，包括專為狹窄缺損和小規模骨移植手術設計的較小容量規格。這提高了臨床醫生的手術柔軟性，並促進了該產品在各種移植適應症中的持續應用。該公司對生物再生領域的廣泛關注也鞏固了其在更廣泛的牙科生物材料市場中的地位。

2025年，亨利·謝恩公司（Henry Schein）透過其子公司BioHorizo​​​​ns成為DBGS市場第二大競爭對手。 BioHorizo​​​​ns提供MinerOss®、Grafton® DBM和LADDEC®等移植材料，涵蓋多種再生醫學適應症。亨利·謝恩公司透過BioHorizo​​​​ns和ACE Southern在同種異體移植、異種移植和合成替代材料領域均有佈局。

2025年，ZimVie是全球DBGS市場第三大競爭對手。其產品系列包括Puros®同種異體移植片、RegenerOss®移植片、Endobon®異種移植片和IngeniOs®合成移植片替代品。 2025年被ARCHIMED收購後，ZimVie已做好充分準備，繼續增加對人工植牙和再生生醫材料的投資。

技術和臨床趨勢

生物衍生移植仍然是一個重要的成長領域。隨著加工、滅菌和可追溯性標準的提高，同種異體移植和異種移植的接受度持續擴大。

異種移植材料仍然是全球重要的移植材料類別。其易得性、穩定的品質和已證實的臨床療效支持其廣泛應用，尤其是在北美以外的地區。

異體移植在北美地區持續表現強勁。該地區受益於成熟的組織庫基礎設施、標準化的供體篩檢和強力的法律規範。

預計合成植入物將在某些地區獲得更大的市場佔有率。它們的供應可以擴大，而且由於它們並非源自人類或動物，因此不存在疾病傳播的風險，這使得它們在那些對生物材料存在監管、文化和倫理顧慮的市場中具有潛在的吸引力。

隨著臨床醫師經驗的積累，優質移植材料的應用也日益廣泛。為了應對更複雜的再生治療病例，皮質骨-鬆質骨混合物、脫鈣骨基質（DBM）糊劑以及特殊形狀的產品正被廣泛使用。

產品形狀的創新也很重要。較小的移植材料、可塑性材料和易於操作的產品為臨床醫生在治療狹窄缺損、保留齒槽窩病例和其他常規骨移植需求方面提供了更大的柔軟性。

地區

本報告涵蓋全球調查區域，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

全球牙科骨植體市場規模有多大？預計到 2032 年將如何成長？

同種異體移植材料、異種移植材料和複合牙科骨移植（DBGS）產品在全球市場上取得了什麼樣的表現？

銷售量、平均售價和市場規模如何隨時間變化？

為什麼人工植牙的成長會持續推高對骨移植替代材料的需求？

不同地區對生物來源移植材料的接受程度如何？

為什麼異種移植材料仍然是全球最大的DBGS材料類別？

臨床醫師的經驗和移植材料的品質如何影響市場價值？

成本障礙、牙齒健康改善和大規模移植手術在限制這種疾病的傳播方面發揮著怎樣的作用？

哪些公司在DBGS市場處於領先地位？ Geistlich、Henry Schein和ZimVie的市場地位如何？

iData Research 的《全球牙科骨植體市場報告》透過詳細的市場規模、平均售價 (ASP) 趨勢、預測和競爭格局分析，解答了這些問題。該報告可用於評估需求、對標主要競爭對手、了解材料趨勢，並制定全球牙科骨植體市場的成長策略。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

牙科骨植體市場

  • 執行摘要
    • 全球牙科骨植體市場概覽
    • 競爭分析
    • 目標市場
    • 目標區域
  • 介紹
    • 自體移植
    • 同種異體移植
    • 異種移植
    • 合成纖維
  • 市場概覽
    • 牙科骨植體市場（按材料分類）
    • 牙科骨植體市場（按地區分類）
  • 市場分析與預測
    • 牙科骨植體的整體市場
    • 牙科骨植體市場（按材料分類）
  • 牙科骨植體數量的分析
    • 依程序類型進行單元分析
  • 促進因素和抑制因素
  • 競爭性市佔率分析

簡稱

Product Code: iDATA_GLDBGS26_DBGS_MC

Global Dental Bone Graft Substitute Market Report to 2032

The global dental bone graft substitute market was valued at $1.19 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 7.3%, reaching nearly $1.95 billion by 2032.

This comprehensive report covers the global market for dental bone graft substitutes (DBGSs), including allograft, xenograft and synthetic DBGS products.

The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Growth is supported by the global expansion of dental implant procedures, rising clinician experience with grafting and increasing acceptance of biologically derived graft materials. However, cost barriers, improving dental health and regional differences in biologic material acceptance continue to shape market performance.

Market Overview

The global dental bone graft substitute market includes materials used to repair bone defects, prepare implant sites and support bone regeneration in dental procedures. DBGS products are most commonly used in implant-related procedures, including socket preservation, sinus augmentation and ridge augmentation.

The market is segmented into allografts, xenografts and synthetic bone graft substitutes. Allografts are derived from human donor tissue, xenografts are derived from animal sources such as bovine or porcine materials, and synthetic grafts are manufactured from non-biologic materials.

In 2025, xenografts represented the largest share of total market value. Xenograft products are widely used in many regions because of their availability, consistent quality and established clinical performance. Allografts represented the second-largest segment, with particularly strong adoption in North America.

Synthetic DBGS products represented the smallest material segment, but they are expected to gain share over the forecast period. Their growth is supported by lower disease transmission concerns, scalable production and use in regions where human- or animal-derived grafts face regulatory, cultural or supply limitations.

Market Drivers

Increased consumer awareness is a major driver of the dental bone graft substitute market. As dental implants become more popular, demand for grafting materials rises because many implant patients require site preparation before implant placement. This connects DBGS growth directly to the broader dental implant market.

Many dental implant companies now offer regenerative materials alongside implant systems. This has increased marketing activity, clinician education and dedicated sales efforts around bone graft substitutes. As companies promote grafting as part of a complete implant workflow, more clinicians and patients become aware of the role DBGS products play in successful implant treatment.

Rising clinician experience is also supporting market growth. Dental professionals who perform bone grafting procedures are becoming more comfortable with available materials and techniques. This has led to greater use of more sophisticated products, including hybrid cortical-cancellous allografts and DBM putties with mineralized bone chips. As clinicians gain confidence, premium-priced products are becoming more common in advanced regenerative procedures.

Market Limiters

Improving dental health is a long-term limiter for the dental bone graft substitute market. In many regions, better awareness of oral health and more frequent dental checkups are reducing edentulism. As aging populations retain better dentition than previous generations, the pool of patients requiring extensive grafting may shrink in certain markets.

Large bone grafting procedures also limit adoption because they can be expensive. Procedures such as ridge augmentation may require 5 cc to 10 cc of graft material. In some cases, the grafting portion of treatment can cost more than the dental implant itself, creating a financial barrier for patients.

Regional acceptance of biologically derived grafts can also limit adoption. Advances in processing, sterilization and traceability have improved confidence in allografts and xenografts, but adoption still varies by regulation, cultural preference, donor tissue availability and clinician comfort. These factors can limit growth in some countries while supporting alternative use of synthetic grafts.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
  • Qualitative coverage: Market drivers and limiters, market size and growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Data types included: Unit sales, average selling prices, market size and growth trends, market drivers and limiters, market forecasts through 2032, historical data, recent mergers and acquisitions, company profiles and product portfolios.
  • Method note: Market revenue is modeled using unit sales and average selling prices, with segmentation by graft material and application used to assess demand across allograft, xenograft and synthetic DBGS products.

The report is designed to help readers evaluate how dental implant growth, material selection, biologic graft acceptance, regional adoption and patient affordability are shaping the global dental bone graft substitute market.

Markets Covered and Segmentation

Dental Bone Graft Substitute Market

  • Type: Allograft, xenograft and synthetic.
  • Application: Socket preservation, sinus augmentation, ridge augmentation and periodontal procedure.

Application segmentation is analyzed at a unit level only.

Allografts include human-derived graft materials used in regenerative dental procedures. These products are especially important in North America, where tissue banking infrastructure and clinician acceptance are well established.

Xenografts include animal-derived graft materials, most commonly bovine or porcine sources. This segment represents the largest share of global DBGS market value.

Synthetic DBGS products are manufactured graft substitutes that do not originate from human or animal sources. These products are relevant in markets where biologic grafts face regulatory, cultural or supply-related limits.

Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Competitive Analysis

In 2025, Geistlich remained the leading competitor in the global dental bone graft substitute market. The company's leadership is driven primarily by its strong position in the xenograft segment, which accounts for a substantial share of DBGS usage outside North America. Its Bio-Oss(R) bovine xenograft portfolio is widely regarded as a clinical reference standard, supported by long-term clinical evidence and global adoption.

Geistlich has continued to refine and expand its Bio-Oss(R) offerings, including smaller-volume formats designed for narrow defects and minor augmentation procedures. This improves procedural flexibility for clinicians and supports continued use across different grafting indications. The company's broader focus on biologically driven regeneration also strengthens its position across the wider dental biomaterials market.

Henry Schein was the second-leading competitor in the DBGS market in 2025 through BioHorizons. BioHorizons offers MinerOss(R), Grafton(R) DBM and LADDEC(R) graft materials, covering several regenerative indications. Through BioHorizons and ACE Southern, Henry Schein participates across allograft, xenograft and synthetic substitute categories.

ZimVie was the third-leading competitor in the global DBGS market in 2025. Its portfolio includes Puros(R) allografts, RegenerOss(R) graft materials, Endobon(R) xenografts and IngeniOs(R) synthetic graft substitutes. Following its 2025 acquisition by ARCHIMED, ZimVie is positioned for continued investment in dental implants and regenerative biomaterials.

Technology and Practice Trends

Biologically derived graft materials remain an important growth area. Allografts and xenografts continue to gain acceptance as processing, sterilization and traceability standards improve.

Xenografts remain a major global material category. Their availability, consistent quality and established clinical performance support wide adoption, especially outside North America.

Allografts continue to perform strongly in North America. The region benefits from mature tissue banking infrastructure, standardized donor screening and strong regulatory oversight.

Synthetic grafts are expected to gain share in certain regions. They offer scalable supply, no human or animal origin and no disease transmission risk, which can make them attractive in markets with regulatory, cultural or ethical concerns around biologic materials.

Premium graft materials are becoming more common as clinicians gain experience. Hybrid cortical-cancellous mixtures, DBM putties and specialized formats are being used to support more complex regenerative cases.

Product format innovation is also important. Smaller-volume graft formats, moldable materials and easier-handling products give clinicians more flexibility when treating narrow defects, socket preservation cases and other routine augmentation needs.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

How large is the global dental bone graft substitute market, and how is it expected to grow through 2032?

How are allograft, xenograft and synthetic DBGS products performing across global markets?

How are unit sales, average selling prices and market values changing over time?

Why does dental implant growth continue to support demand for bone graft substitutes?

How are biologically derived graft materials gaining acceptance across different regions?

Why do xenografts remain the largest DBGS material category globally?

How are clinician experience and premium graft materials affecting market value?

What role do cost barriers, improving dental health and large grafting procedures play in limiting adoption?

Which companies lead the DBGS market, and how are Geistlich, Henry Schein and ZimVie positioned?

The Global Dental Bone Graft Substitute Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, understand material trends and plan for growth across the global dental bone graft substitute market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Dental Bone Graft Substitute Market

  • 4.1 Executive Summary
    • 4.1.1 Global Dental Bone Graft Substitute Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Markets Included
    • 4.1.4 Regions Included
  • 4.2 Introduction
    • 4.2.1 Autografts
    • 4.2.2 Allografts
      • 4.2.2.1 Mineralized Allografts
      • 4.2.2.2 Demineralized Bone Matrix
    • 4.2.3 Xenografts
    • 4.2.4 Synthetics
  • 4.3 Market Overview
    • 4.3.1 Dental Bone Graft Substitute Market By Material
    • 4.3.2 Dental Bone Graft Substitute Market By Region
  • 4.4 Market Analysis And Forecast
    • 4.4.1 Total Dental Bone Graft Substitute Market
    • 4.4.2 Dental Bone Graft Substitute Market By Material
      • 4.4.2.1 Allograft Market
      • 4.4.2.2 Xenograft Market
      • 4.4.2.3 Synthetic Market
  • 4.5 Dental Bone Graft Substitute Unit Analysis
    • 4.5.1 Unit Analysis By Procedure Type
      • 4.5.1.1 Socket Preservation
      • 4.5.1.2 Sinus Augmentation
      • 4.5.1.3 Ridge Augmentation
      • 4.5.1.4 Periodontal Procedures
  • 4.6 Drivers And Limiters
    • 4.6.1 Market Drivers
    • 4.6.2 Market Limiters
  • 4.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 4-1: Dental Bone Graft Substitute Market, Global, 2025 & 2032
  • Chart 4-2: Dental Bone Graft Substitute Procedures, Global, 2025
  • Chart 4-3: Dental Bone Graft Substitute Market by Material, Global, 2022 - 2032
  • Chart 4-4: Dental Bone Graft Substitute Market by Region, Global, 2022 - 2032
  • Chart 4-5: Leading Competitors, Dental Bone Graft Substitute Market, Global, 2025

LIST OF FIGURES

  • Figure 4-1: Dental Bone Graft Substitute Markets Covered
  • Figure 4-2: Dental Bone Graft Substitute Regions Covered, Global (1 of 2)
  • Figure 4-3: Dental Bone Graft Substitute Regions Covered, Global (2 of 2)
  • Figure 4-4: Dental Bone Graft Substitute Market by Material, Global, 2022 - 2032 (US$M)
  • Figure 4-5: Dental Bone Graft Substitute Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 4-6: Dental Bone Graft Substitute Market, Global, 2022 - 2032
  • Figure 4-7: Units Sold (cc) by Region, Dental Bone Graft Substitute Market, Global, 2022 - 2032
  • Figure 4-8: Average Selling Price by Region, Dental Bone Graft Substitute Market, Global, 2022 - 2032 (US$)
  • Figure 4-9: Market Value by Region, Dental Bone Graft Substitute Market, Global, 2022 - 2032 (US$M)
  • Figure 4-10: Allograft Market, Global, 2022 - 2032
  • Figure 4-11: Units Sold (cc) by Region, Allograft Market, Global, 2022 - 2032
  • Figure 4-12: Average Selling Price by Region, Allograft Market, Global, 2022 - 2032 (US$)
  • Figure 4-13: Market Value by Region, Allograft Market, Global, 2022 - 2032 (US$M)
  • Figure 4-14: Xenograft Market, Global, 2022 - 2032
  • Figure 4-15: Units Sold (cc) by Region, Xenograft Market, Global, 2022 - 2032
  • Figure 4-16: Average Selling Price by Region, Xenograft Market, Global, 2022 - 2032 (US$)
  • Figure 4-17: Market Value by Region, Xenograft Market, Global, 2022 - 2032 (US$M)
  • Figure 4-18: Synthetic Market, Global, 2022 - 2032
  • Figure 4-19: Units Sold (cc) by Region, Synthetic Market, Global, 2022 - 2032
  • Figure 4-20: Average Selling Price by Region, Synthetic Market, Global, 2022 - 2032 (US$)
  • Figure 4-21: Market Value by Region, Synthetic Market, Global, 2022 - 2032 (US$M)
  • Figure 4-22: Dental Bone Graft Substitute Units Sold (cc) by Procedure Type, Global, 2022 - 2032
  • Figure 4-23: Socket Preservation Procedure Units Sold (cc) by Region, Global, 2022 - 2032
  • Figure 4-24: Sinus Augmentation Procedure Units Sold (cc) by Region, Global, 2022 - 2032
  • Figure 4-25: Ridge Augmentation Procedure Units Sold (cc) by Region, Global, 2022 - 2032
  • Figure 4-26: Periodontal Procedure Units Sold (cc) by Region, Global, 2022 - 2032
  • Figure 4-27: Leading Competitors, Dental Bone Graft Substitute Market, Global, 2025 (1 of 2)
  • Figure 4-28: Leading Competitors, Dental Bone Graft Substitute Market, Global, 2025 (2 of 2)